NorDiag ASA

We at NorDiag have developed a novel, proprietary DNA-based technology for cancer testing. We believe our technology will help increase patient participation in cancer screening programmes and hasten the successful launch of new screening programmes. Key benefits to our product Genefec™ are its non-invasiveness, scalability, cost-effectiveness and its accuracy at the early stages of cancer development. Early detection gives the best chances for successful treatment.

Contact Details: Thormøhlensgate 55 Bergen N-5008 Norway Tel: 47 55 54 39 60 Fax: 47 55 54 38 98 Email: info@nordiag.no WWW: www.nordiag.no/

BioNews Results for NorDiag ASA:
A Case-Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time	Journal of the National Cancer Institute:  Nov 21 2009 9:39AM Matching: asa
Photocure reports upcoming FDA advisory committee meeting to discuss Hexvix	Individual.com:  Nov 21 2009 6:41AM Matching: asa
Pronova BioPharma ASA presented at "Aksjedagen Norge" 2009	Individual.com:  Nov 20 2009 7:00AM Matching: asa
DxNA announces successfull evaluation of its GeneSTAT PCR system	News-Medical.Net:  Nov 19 2009 4:10PM Matching: asa
GTS, the first company to develop and commercialize a unique form of ultrasound technology	News-Medical.Net:  Nov 19 2009 7:07AM Matching: asa
Promote your company here: BioNewsCast - Press Release Distribution	→View more NorDiag ASA news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 347 times since April 2007, the link to the organisation's website has been followed 52 times

Search for more companies in Bergen

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for NorDiag ASA